Insights

Innovative Vaccine Platform Medicago specializes in plant-based vaccine development using tobacco plants as bioreactors, offering a unique production method that can appeal to organizations seeking novel biologic manufacturing solutions.

Recent Facility Expansions The company has invested over $121 million in new manufacturing facilities and expanded its infrastructure in Quebec City, indicating capacity for large-scale vaccine production and potential for partnerships in biologics supply chains.

Strong Government Support Medicago received substantial federal funding over $300 million for vaccine manufacturing projects, signifying government backing and highlighting opportunities for government contracts or collaborations with public health entities.

Acquisition and Strategic Shift The company's recent acquisition by Mitsubishi Tanabe Pharma and the cessation of certain operations suggest a shift in strategic focus, potentially opening avenues for partnerships, licensing, or licensing-in opportunities with a financially backed biotech innovator.

Emerging Biotech Niche Medicago operates within a niche of plant-based, rapid-response vaccine technologies amid evolving global health needs, presenting potential for sales in vaccine ingredients, bioprocessing equipment, or related biotech solutions aimed at pandemic preparedness.

Medicago Tech Stack

Medicago uses 8 technology products and services including Google Fonts API, yepnope.js, jQuery, and more. Explore Medicago's tech stack below.

  • Google Fonts API
    Font Scripts
  • yepnope.js
    Javascript Frameworks
  • jQuery
    Javascript Libraries
  • Modernizr
    Javascript Libraries
  • Dojo Toolkit
    Javascript Libraries
  • Windows Server
    Operating Systems
  • Nginx
    Web Servers
  • Microsoft IIS
    Web Servers

Media & News

Medicago's Email Address Formats

Medicago uses at least 1 format(s):
Medicago Email FormatsExamplePercentage
LastF@medicago.comDoeJ@medicago.com
90%
First.Last@medicago.comJohn.Doe@medicago.com
9%
FLast@medicago.comJDoe@medicago.com
1%

Frequently Asked Questions

Where is Medicago's headquarters located?

Minus sign iconPlus sign icon
Medicago's main headquarters is located at 1020 Route de L'église Suite 710 Quebec, Quebec g1v 3v9 Canada. The company has employees across 3 continents, including North AmericaSouth AmericaEurope.

What is Medicago's phone number?

Minus sign iconPlus sign icon
You can contact Medicago's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Medicago's official website and social media links?

Minus sign iconPlus sign icon
Medicago's official website is medicago.com and has social profiles on LinkedIn.

What is Medicago's SIC code NAICS code?

Minus sign iconPlus sign icon
Medicago's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Medicago have currently?

Minus sign iconPlus sign icon
As of April 2026, Medicago has approximately 265 employees across 3 continents, including North AmericaSouth AmericaEurope. Key team members include Chief Financial Officer: M. M.Chief Compliance Officer: B. B.Vice President Business Development, Sales&marketing: J. M.. Explore Medicago's employee directory with LeadIQ.

What industry does Medicago belong to?

Minus sign iconPlus sign icon
Medicago operates in the Biotechnology Research industry.

What technology does Medicago use?

Minus sign iconPlus sign icon
Medicago's tech stack includes Google Fonts APIyepnope.jsjQueryModernizrDojo ToolkitWindows ServerNginxMicrosoft IIS.

What is Medicago's email format?

Minus sign iconPlus sign icon
Medicago's email format typically follows the pattern of LastF@medicago.com. Find more Medicago email formats with LeadIQ.

How much funding has Medicago raised to date?

Minus sign iconPlus sign icon
As of April 2026, Medicago has raised $132M in funding. The last funding round occurred on Oct 23, 2020 for $132M.

When was Medicago founded?

Minus sign iconPlus sign icon
Medicago was founded in 1999.

Medicago

Biotechnology ResearchQuebec, Canada201-500 Employees

Medicago develops vaccines and treatments to help fight emerging global health challenges, today and in the future. Please note that we may come across a situation not outlined above that will require the removal of your comment. Please know that Medicago reserves the right to delete any comment at its sole discretion. If you feel your comment has been unfairly removed, please contact us. For information about our commenting guidelines, please visit: http://ow.ly/6mKh50HKyUR

Medicago développe des vaccins et des traitements pour répondre rapidement aux nouveaux défis de santé mondiaux.
Medicago se réserve le droit de supprimer tout commentaire à sa seule discrétion. Si vous estimez que votre commentaire a été injustement retiré, veuillez communiquer avec nous. Pour plus d’information sur nos conditions d’utilisation, visitez notre page Nétiquette: http://ow.ly/vXuO50HKFSU

Section iconCompany Overview

Headquarters
1020 Route de L'église Suite 710 Quebec, Quebec g1v 3v9 Canada
Phone number
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
1999
Employees
201-500

Section iconFunding & Financials

  • $132M

    Medicago has raised a total of $132M of funding over 7 rounds. Their latest funding round was raised on Oct 23, 2020 in the amount of $132M.

Section iconFunding & Financials

  • $132M

    Medicago has raised a total of $132M of funding over 7 rounds. Their latest funding round was raised on Oct 23, 2020 in the amount of $132M.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.